Published in J Clin Pathol on July 01, 1983
Serum amyloid A: an acute-phase protein involved in tumour pathogenesis. Cell Mol Life Sci (2009) 1.57
Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer. Ann Surg (1991) 1.36
Acute phase response of serum amyloid A protein and C reactive protein to the common cold and influenza. J Clin Pathol (1985) 1.25
Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry. Proc Natl Acad Sci U S A (2004) 1.15
Serum amyloid A (SAA) variations in patients with cancer: correlation with disease activity, stage, primary site, and prognosis. J Clin Pathol (1986) 1.03
Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers. Int J Cancer (2012) 0.97
Serum amyloid A protein in acute viral infections. Arch Dis Child (1993) 0.89
Differential expression of host biomarkers in saliva and serum samples from individuals with suspected pulmonary tuberculosis. Mediators Inflamm (2013) 0.84
Acute phase reaction during chemotherapy in small cell lung cancer. Br J Cancer (1989) 0.83
Serum amyloid A, C-reactive protein, and retinal microvascular changes in hypertensive diabetic and nondiabetic individuals: an Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) substudy. Diabetes Care (2009) 0.82
Biomarkers of Inflammation and Immune Function and Risk of Colorectal Cancer. Curr Colorectal Cancer Rep (2015) 0.82
Comparative study of C reactive protein and serum amyloid A protein in experimental inflammation. Ann Rheum Dis (1991) 0.80
Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma. Br J Cancer (2012) 0.79
Potential biomarkers in the sera of breast cancer patients from bahawalpur, pakistan. Biomark Cancer (2012) 0.77
Second annual meeting of the Association of Cancer Physicians (in conjunction with the 28th AGM of the British Association for Cancer Research). April 6-8, 1987, Newcastle-upon-Tyne, UK. Abstracts. Br J Cancer (1987) 0.75
Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry (1965) 96.68
Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem (1966) 21.70
Crossed immunoelectrophoresis. Scand J Immunol Suppl (1973) 4.51
Immunologic studies of the major nonimmunoglobulin protein of amyloid. I. Identification and partial characterization of a related serum component. J Exp Med (1973) 3.22
Variation with age and disease of an amyloid A protein-related serum component. J Clin Invest (1975) 3.17
Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc Natl Acad Sci U S A (1977) 3.04
A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils. J Clin Invest (1974) 2.78
Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis. Lancet (1982) 2.10
Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation. J Clin Invest (1978) 1.90
Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin. Proc Natl Acad Sci U S A (1975) 1.84
Serum C-reactive protein levels in disease. Ann N Y Acad Sci (1982) 1.75
Serum amyloid A protein in amyloidosis, rheumatic, and enoplastic diseases. Arthritis Rheum (1979) 1.53
Synthesis and secretion of serum amyloid protein A (SAA) by hepatocytes in mice treated with casein. J Immunol (1980) 1.44
High-density lipoprotein as carrier for amyloid-related protein SAA in rabbit serum. Scand J Immunol (1979) 1.41
Amyloid-related serum component (SAA)--studies in acute infections, medullary thyroid carcinoma, and postsurgery. Clin Immunol Immunopathol (1976) 1.27
Serum amyloid A to monitor cancer dissemination. Ann Intern Med (1979) 1.16
Levels of the serum amyloid A protein (SAA) in normal persons of different age groups. Clin Exp Immunol (1979) 0.99
Relationship between urinary sialylated saccharides, serum amyloid A protein, and C-reactive protein in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis (1982) 0.95
Control of the acute-phase response. C-reactive protein synthesis by isolated perfused rabbit livers. J Lab Clin Med (1980) 0.88
Occurrence of amyloid-related serum proteins in patients with benign monoclonal gammopathy. Scand J Immunol (1977) 0.87
Is there an acute-phase response in steady-state sickle cell disease? Lancet (1993) 2.35
Biochemical monitoring of cancer. A review. Ann Clin Biochem (1976) 1.83
Evaluation of dimethylhydrazine induced tumours in mice as a model system for colorectal cancer. Br J Cancer (1973) 1.83
Alpha-1-microglobulin: an indicator protein for renal tubular function. J Clin Pathol (1983) 1.80
Role of serial plasma C.E.A. assays in detection of recurrent and metastatic colorectal carcinomas. Br Med J (1974) 1.69
Renal proximal dysfunction in patients with rheumatic diseases. Br Med J (Clin Res Ed) (1984) 1.57
TNM classification of genitourinary tumours 1987--position of the EORTC Genitourinary Group. Br J Urol (1988) 1.55
Sodium dodecyl sulphate polyacrylamide gel electrophoresis patterns of proteinuria in various renal diseases of childhood. Pediatr Nephrol (1991) 1.47
Quantitation of the response of lymphocytes in culture to specific and non-specific stimulation. Int Arch Allergy Appl Immunol (1967) 1.44
[Degradation of thymidine by transformed lymphocytes]. Rev Fr Etud Clin Biol (1965) 1.43
Species of alpha-hemolytic streptococci possessing a C-polysaccharide phosphorylcholine-containing antigen. Infect Immun (1993) 1.42
Analyses of DNA content, nuclear size and cell proliferation of transitional cell carcinoma in man. Cancer (1969) 1.41
Proliferation and ultrastructure of papillary transitional cell carcinoma of the human bladder. Cancer (1971) 1.41
Immunologically stimulated human peripheral blood lymphocytes in vitro. I. Morphological changes. Int Arch Allergy Appl Immunol (1966) 1.37
C reactive protein: an aid to assessment and monitoring of acute pancreatitis. J Clin Pathol (1984) 1.34
Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas: findings in a multicenter study and experience in selected patients. Cancer (1980) 1.31
Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis (1993) 1.30
Cancer of the urinary tract. Adv Cancer Res (1970) 1.28
Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer. Br J Cancer (1985) 1.25
Cell proliferation in Burkitt tumours. Eur J Cancer (1966) 1.25
Acute-phase reactant protein profiles: an aid to monitoring large bowel cancer by CEA and serum enzymes. Br J Cancer (1977) 1.24
Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: a clinical and computer analysis. Br J Surg (1985) 1.23
Influence of morbidity on serum retinol of children in a community-based study in northern Ghana. Am J Clin Nutr (1993) 1.23
Cell death in normal and malignant tissues. Adv Cancer Res (1975) 1.22
Serum beta 2-microglobulin and C reactive protein concentrations in viral infections. J Clin Pathol (1984) 1.22
Relation of alpha 2-macroglobulin and other antiproteases to the clinical features of acute pancreatitis. Am J Surg (1984) 1.20
The prognostic influence of serum neuron specific enolase in small cell lung cancer. Br J Cancer (1988) 1.18
Acute-phase protein response is impaired in severely malnourished children. Clin Sci (Lond) (1993) 1.17
Tubular dysfunction and microalbuminuria in insulin dependent diabetes. Arch Dis Child (1988) 1.16
The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer. Br J Cancer (1993) 1.15
Results of the MRC myelomatosis trials for patients entered since 1980. Hematol Oncol (1988) 1.15
The prognostic value of serum beta 2 microglobulin compared with other presentation features in myelomatosis. Br J Cancer (1985) 1.15
Measurement of acute phase proteins for assessing severity of Plasmodium falciparum malaria. J Clin Pathol (1991) 1.14
Proliferation characteristics of the various classes of cells in Hodgkin's disease. Cancer (1969) 1.14
CEA and tumor markers. Semin Oncol (1976) 1.13
Acute phase reactant proteins in cancer. Adv Cancer Res (1979) 1.12
Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer. Eur J Cancer Clin Oncol (1989) 1.10
Serum beta 2-microglobulin in myelomatosis: potential value in stratification and monitoring. Br J Cancer (1980) 1.08
Proximal renal tubular function in myelomatosis: observations in the fourth Medical Research Council trial. J Clin Pathol (1984) 1.07
Proliferative activity of leukaemic cells at various stages of acute leukaemia of childhood. Br J Haematol (1968) 1.04
The biology of cell death in tumours. Cell Tissue Kinet (1973) 1.03
The thoracic duct lymph in Hodgkin's disease. II. Quantitative analysis of the cellular composition of the lymph. Int J Cancer (1971) 1.02
Lymphocyte infiltration in bladder carcinoma. Rev Eur Etud Clin Biol (1970) 1.01
Alpha-globulins in the surveillance of colorectal cancer. Biomedicine (1976) 1.01
Rouleaux-forming serum proteins are involved in the rosetting of Plasmodium falciparum-infected erythrocytes. Exp Parasitol (1999) 1.00
Cell proliferation in human malignant lymphomas. Analysis of labelling index and DNA content in cell populations obtained by biopsy. Eur J Cancer (1968) 1.00
Chromosome constitution of transitional cell carcinoma of the urinary bladder. Cancer (1972) 0.99
Serum beta 2-microglobulin and human immunodeficiency virus infection. AIDS (1987) 0.99
Serum hyaluronate as a marker of hepatic derangement in acute liver damage. J Hepatol (1991) 0.97
DNA synthesis and DNA content of leucocytes in acute leukaemia. Nature (1967) 0.97
Blood muramidase activity in colorectal cancer. Br Med J (1974) 0.97
Disorganization of mouse bladder epithelium induced by 2-acetylaminofluorene and 4-ethylsulfonylnaphthalene-1-sulfonamide. J Natl Cancer Inst (1971) 0.96
The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer. Br J Cancer (1994) 0.95
Long-term prognostic value of serum beta 2 microglobulin in myelomatosis. Br J Haematol (1990) 0.95
Vitamin A supplementation, morbidity, and serum acute-phase proteins in young Ghanaian children. Am J Clin Nutr (1995) 0.95
DNA metabolism of the immunoglobulin-containing cells in the lymph nodes of rats. J Reticuloendothel Soc (1965) 0.95
Beta-2-microglobulin review: its relevance in clinical oncology. Med Pediatr Oncol (1980) 0.94
Combination of carcinoembryonic antigen and gamma glutamyl transpeptidase in the study of the evolution of colorectal cancer. Br J Cancer (1974) 0.94
Neopterin, beta 2-microglobulin, and acute phase proteins in HIV-1-seropositive and -seronegative Zambian patients with tuberculosis. Lung (1997) 0.94
Acute phase reactant proteins in prostatic cancer. Br J Urol (1977) 0.93
Amyloidosis: a global problem common in Papua New Guinea. P N G Med J (1996) 0.93
The monitoring role of plasma CEA alone and in association with other tumor markers in colorectal and mammary carcinoma. Cancer (1978) 0.93
The contribution of serum enzymes and carcinoembryonic antigen to the early diagnosis of metastatic colorectal cancer. Br J Cancer (1975) 0.93
Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancer. Br J Cancer (1983) 0.92
C-reactive protein binds to a novel ligand on Leishmania donovani and increases uptake into human macrophages. J Immunol (1996) 0.92
Plasma protein profiles and prognosis in gastric cancer. Br J Cancer (1982) 0.92
The evolution of tumour cell populations in human bladder cancer. Br J Urol (1969) 0.92
Multivariate biochemical indicators of breast cancer: an evaluation of their potential in routine practice. Eur J Cancer (1978) 0.91
Interferon-gamma mediates host resistance in a murine model of melioidosis. Biochem Soc Trans (1997) 0.91
Prognostic significance of serum proteins in invasive bladder cancer. A preliminary report of the E.O.R.T.C. Urological Group. Eur J Cancer (1981) 0.91
Accumulation of calcium in the intramitochondrial dense bodies in mice. Exp Cell Res (1972) 0.91
Neuron-specific enolase as a guide to the treatment of small cell lung cancer. Eur J Cancer Clin Oncol (1987) 0.90
Activity of JM9 in advanced ovarian cancer: a phase I-II trial. Cancer Treat Rep (1985) 0.90
Repair of rat urinary bladder epithelium following injury by cyclophosphamide. Invest Urol (1970) 0.89
Proliferative potential of out-of-cycle leukaemic cells. Nature (1969) 0.89
The amylase-to-creatinine clearance ratio--a non-specific response to acute illness? Br J Surg (1982) 0.89
Hyaluronic acid in the assessment of liver graft function. Transplant Proc (1990) 0.89
The use of concanavalin A crossed immuno-affinoelectrophoresis to detect hormone-associated variations in alpha 1-acid glycoprotein. Clin Chim Acta (1981) 0.89
Acute phase serum amyloid A protein increases high density lipoprotein binding to human peripheral blood mononuclear cells and an endothelial cell line. Scand J Immunol (2000) 0.88
Urinary protein profiles after burn injury. Burns Incl Therm Inj (1983) 0.88
Isoelectric points of urinary light chains in myelomatosis: analysis in relation to nephrotoxicity. J Clin Pathol (1986) 0.88
Application of monoclonal antibodies to purified CEA in clinical radioimmunoassay of human serum. Br J Cancer (1981) 0.88
Disturbed proliferation of erythropoietic cells in pernicious anemia. Nature (1967) 0.88
Behaviour of serum beta 2-microglobulin and acute phase reactant proteins in chronic lymphocytic leukaemia. A multicentre study. Acta Haematol (1980) 0.87
Acute phase reactant proteins as aids to monitoring disease. Invest Cell Pathol (1980) 0.86
The tumour marker CA 195 in colorectal and pancreatic cancer. Int J Biol Markers (1992) 0.86
Acute-phase HDL in phospholipid transfer protein (PLTP)-mediated HDL conversion. Atherosclerosis (2001) 0.86
Serum prealbumin, retinol-binding protein, transferrin, and albumin levels in patients with large bowel cancer. J Natl Cancer Inst (1978) 0.86
Bone alkaline phosphatase in rheumatoid arthritis: a longitudinal study. J Rheumatol (1996) 0.86
Identification and measurement of paraprotein polymers by high performance gel filtration chromatography. Biomed Pharmacother (1985) 0.86
Transmissible venereal sarcoma of dogs. A histochemical and chromosomal analysis of tumours in Uganda. Rev Eur Etud Clin Biol (1970) 0.86
Serum beta 2-microglobulin in malignant and benign diseases of the stomach and pancreas. Biomedicine (1981) 0.85
Arrest of cell proliferation and protein synthesis in megaloblasts of pernicious anaemia. Acta Haematol (1969) 0.85
Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC). Br J Cancer (1992) 0.84
Clinical evaluation of serum tissue polypeptide-specific antigen (TPS) in non-small cell lung cancer. Eur J Cancer (1994) 0.84
Acute phase protein concentrations predict parasite clearance rate during therapy for visceral leishmaniasis. Trans R Soc Trop Med Hyg (1996) 0.84
Deoxyribonucleic acid content of antibody-containing cells in the rat lymph node. Nature (1965) 0.84
Cell proliferation in colonic mucosa and carcinoma of the colon. Proc R Soc Med (1973) 0.83